bf/NASDAQ:PRQR_icon.png

COM:PROQR

ProQR Therapeutics

  • Stock

Last Close

3.98

13/11 21:00

Market Cap

323.38M

Beta: -

Volume Today

1.30M

Avg: -

ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.

peer of